Ergotamine Tartrate And Caffeine

   
Google
 
Web NewDrugInformation.com

Ergotamine Tartrate And Caffeine


Drug - Ergotamine Tartrate And Caffeine
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Caffeine; Ergotamine Tartrate
Multiple ingredients are in alphabetical order.

Strength - 100MG;1MG
The potency of the active ingredient(s), Caffeine; Ergotamine Tartrate. May repeat for multiple part products.

Applicant - MIKART
The firm name holding legal responsibility for Ergotamine Tartrate And Caffeine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 040590
The FDA assigned number to Ergotamine Tartrate And Caffeine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ergotamine Tartrate And Caffeine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AA
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 16, 2005
The date Ergotamine Tartrate And Caffeine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ergotamine Tartrate And Caffeine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ergotamine Tartrate And Caffeine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mikart Inc
The full name of the firm holding legal responsibility for the new application of Ergotamine Tartrate And Caffeine.

Ergotamine Tartrate And Caffeine